SMTL ID : 3fei.1

Design and biological evaluation of novel, balanced dual PPARa/g agonists

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-mer

Ligands

1 x CTM: (2S)-3-(4-{[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methoxy}-2-methylphenyl)-2-ethoxypropanoic acid(Non-covalent)

CTM.1: 17 residues within 4Å: Chain A: L.46, F.72, C.74, C.75, S.79, Y.113, F.117, L.120, M.129, V.131, I.138, M.154, K.157, H.239, V.243, L.259, Y.263 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.46, A:F.72, A:Y.113, A:F.117, A:L.120, A:V.131, A:V.131, A:I.138 Hydrogen bonds: A:S.79, A:S.79 Salt bridges: A:H.239

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Grether, U. et al., Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists. Chemmedchem (2009)

Release Date

2009-10-20

Peptides

Peroxisome proliferator-activated receptor alpha: A
Peptide motif 5 of Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
Z

Peroxisome proliferator-activated receptor alpha

Peptide motif 5 of Nuclear receptor coactivator 1

Related Entries With Identical Sequence